<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/ownership" xmlns:com="http://www.sec.gov/edgar/common">
  <headerData>
    <submissionType>144</submissionType>
    <filerInfo>
      <filer>
        <filerCredentials>
          <!-- Field: Pseudo-Tag; ID: Name; Data: TPG Biotechnology Partners III, L.P. -->
          <cik>0001973071</cik>
          <ccc>XXXXXXXX</ccc>
        </filerCredentials>
      </filer>
      <liveTestFlag>LIVE</liveTestFlag>


    </filerInfo>
  </headerData>
  <formData>
    <issuerInfo>
      <issuerCik>0001551306</issuerCik>
      <issuerName>Progyny, Inc.</issuerName>
      <secFileNumber>001-39100</secFileNumber>
      <issuerAddress>
        <com:street1>1359 Broadway</com:street1>
        <com:city>New York</com:city>
        <com:stateOrCountry>NY</com:stateOrCountry>
        <com:zipCode>10018</com:zipCode>
      </issuerAddress>
      <issuerContactPhone>212-888-3124</issuerContactPhone>
      <nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>TPG Biotechnology Partners III, L.P.</nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>
      <relationshipsToIssuer>
        <relationshipToIssuer>Stockholder</relationshipToIssuer>
      </relationshipsToIssuer>
    </issuerInfo>
    <securitiesInformation>
      <securitiesClassTitle>Common Stock, $0.0001 par value per share</securitiesClassTitle>
      <brokerOrMarketmakerDetails>
        <name>BofA Securities, Inc.</name>
        <address>
          <com:street1>One Bryant Park</com:street1>
          <com:street2>5th Floor</com:street2>
          <com:city>New York</com:city>
          <com:stateOrCountry>NY</com:stateOrCountry>
          <com:zipCode>10036</com:zipCode>
        </address>
      </brokerOrMarketmakerDetails>
      <noOfUnitsSold>2900000</noOfUnitsSold>
      <aggregateMarketValue>124410000.00</aggregateMarketValue>
      <noOfUnitsOutstanding>95406381</noOfUnitsOutstanding>
      <approxSaleDate>08/07/2023</approxSaleDate>
      <securitiesExchangeName>NASDAQGS</securitiesExchangeName>
    </securitiesInformation>
    <securitiesToBeSold>
      <securitiesClassTitle>Common Stock, $0.0001 par value per share</securitiesClassTitle>
      <acquiredDate>10/29/2019</acquiredDate>
      <natureOfAcquisitionTransaction>The shares of Common Stock reported herein were originally acquired by Seller on October 29, 2019 upon the automatic conversion of shares of Preferred Stock of the Issuer into shares of Common Stock.</natureOfAcquisitionTransaction>
      <nameOfPersonfromWhomAcquired>Issuer</nameOfPersonfromWhomAcquired>
      <isGiftTransaction>N</isGiftTransaction>
      <amountOfSecuritiesAcquired>18905943</amountOfSecuritiesAcquired>
      <paymentDate>10/29/2019</paymentDate>
      <natureOfPayment>Automatic conversion of shares of Preferred Stock of the Issuer into shares of Common Stock.</natureOfPayment>
    </securitiesToBeSold>
    <nothingToReportFlagOnSecuritiesSoldInPast3Months>Y</nothingToReportFlagOnSecuritiesSoldInPast3Months>
    <noticeSignature>
      <noticeDate>08/07/2023</noticeDate>
      <signature>/s/ Ken Murphy</signature>
    </noticeSignature>
  </formData>
</edgarSubmission>
[{"type": "144", "sequence": "1", "filename": "primary_doc.xml", "secsgml_size_bytes": 3191}]
144
0001973071
XXXXXXXX
LIVE
0001551306
Progyny, Inc.
001-39100
1359 Broadway
New York
NY
10018
212-888-3124
TPG Biotechnology Partners III, L.P.
Stockholder
Common Stock, $0.0001 par value per share
BofA Securities, Inc.
One Bryant Park
5th Floor
New York
NY
10036
2900000
124410000.00
95406381
08/07/2023
NASDAQGS
Common Stock, $0.0001 par value per share
10/29/2019
The shares of Common Stock reported herein were originally acquired by Seller on October 29, 2019 upon the automatic conversion of shares of Preferred Stock of the Issuer into shares of Common Stock.
Issuer
N
18905943
10/29/2019
Automatic conversion of shares of Preferred Stock of the Issuer into shares of Common Stock.
Y
08/07/2023
/s/ Ken Murphy